Hims & Hers (HIMS) legal chief earns 273,794 performance stock units

Rhea-AI Filing Summary

Hims & Hers Health, Inc. reported that Chief Legal Officer Boughton Soleil acquired 273,794 shares of Class A common stock through a performance-based restricted stock unit (PRSU) award. The award carried a price of $0.00 per share and lifted Soleil’s directly held stake to 445,623 shares.

The PRSUs were earned under a previously granted award after the Compensation Committee certified that the performance criteria were met as of February 23, 2026. Under the award terms, the underlying shares are scheduled to be delivered to Soleil on or about March 15, 2026.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Boughton Soleil

Role Chief Legal Officer

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	273,794	$0.00	--

Holdings After Transaction: Class A Common Stock — 445,623 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Boughton Soleil

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CA 94123

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	02/23/2026		A		273,794(1)	A	$0	445,623	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents performance-based restricted stock units (PRSUs) earned pursuant to a previously granted award. Each PRSU represents a contingent right to receive one share of the Company's Class A common stock. The Compensation Committee of the Company's Board of Directors certified that the performance criteria established in connection with this award has been met as of February 23, 2026. In accordance with the award's terms, the shares underlying the PRSUs will be delivered to the Reporting Person on or about March 15, 2026.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Soleil Boughton	02/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did HIMS report for Boughton Soleil?

Hims & Hers Health, Inc. reported that Chief Legal Officer Boughton Soleil acquired 273,794 Class A shares via a performance-based restricted stock unit award. These shares were granted at $0.00 per share following certification that the award’s performance criteria were achieved.

How many HIMS shares does Boughton Soleil hold after this Form 4?

After the reported grant, Boughton Soleil directly holds 445,623 shares of Hims & Hers Health, Inc. Class A common stock. This total reflects the addition of 273,794 shares earned under a performance-based restricted stock unit award tied to previously established performance goals.

What type of equity award did Boughton Soleil receive from Hims & Hers (HIMS)?

Boughton Soleil received performance-based restricted stock units (PRSUs), each representing a contingent right to one Hims & Hers Class A share. The award was previously granted, with shares earned once the Compensation Committee certified performance criteria had been satisfied as of February 23, 2026.

When will the PRSU shares for HIMS be delivered to Boughton Soleil?

Under the award terms, the shares underlying the performance-based restricted stock units will be delivered to Boughton Soleil on or about March 15, 2026. This delivery follows the Compensation Committee’s certification that the required performance conditions were met on February 23, 2026.

Was cash paid for the HIMS shares reported in this Form 4?

No cash was paid for these Hims & Hers shares; the Form 4 lists a price of $0.00 per share. The 273,794 shares were earned as part of a performance-based restricted stock unit award rather than purchased in an open-market or cash transaction.

What role does Boughton Soleil hold at Hims & Hers Health, Inc. (HIMS)?

Boughton Soleil serves as Chief Legal Officer at Hims & Hers Health, Inc. The reported Form 4 transaction reflects equity compensation in the form of performance-based restricted stock units that converted into 273,794 Class A shares after meeting specified performance conditions.